Skip to main content

REVIEW article

Front. Genome Ed.
Sec. Genome Editing in Animals
Volume 6 - 2024 | doi: 10.3389/fgeed.2024.1401163

A gene edited pig model for studying LGR5+ stem cells: implications for future applications in tissue regeneration and biomedical research Provisionally Accepted

 Amanda B. Hill1, 2 Yanet M. Murphy1, 2 Kathryn M. Polkoff1, 2 Laura Edwards1, 2 Derek M. Walker1  Adele Moatti1, 3  Alon Greenbaum1, 4  Jorge A. Piedrahita1, 2*
  • 1Comparative Medicine Institute, North Carolina State University, United States
  • 2College of Veterinary Medicine, North Carolina State University, United States
  • 3Joint Department of Biomedical Engineering, University of North Carolina, Chapel Hill and North Carolina State University, United States
  • 4Joint department of Biomedical Engineering at University of North Carolina, Chapel Hill and North Carolina State University, United States

The final, formatted version of the article will be published soon.

Receive an email when it is updated
You just subscribed to receive the final version of the article

Recent advancements in genome editing techniques, notably CRISPR-Cas9 and TALENs, have marked a transformative era in biomedical research, significantly enhancing our understanding of disease mechanisms and helping develop novel therapies. These technologies have been instrumental in creating precise animal models for use in stem cell research and regenerative medicine. For instance, we have developed a transgenic pig model to enable the investigation of LGR5-expressing cells. The model was designed to induce the expression of H2B-GFP under the regulatory control of the LGR5 promoter via CRISPR/Cas9-mediated gene knock-in. Notably, advancements in stem cell research have identified distinct subpopulations of LGR5-expressing cells within adult human, mouse, and pig tissues. LGR5, a leucine-rich repeat-containing G protein-coupled receptor, enhances WNT signaling and these LGR5+ subpopulations demonstrate varied roles and anatomical distributions, underscoring the necessity for suitable translational models. This transgenic pig model facilitates the tracking of LGR5-expressing cells and has provided valuable insights into the roles of these cells across different tissues and species. For instance, in pulmonary tissue, Lgr5+ cells in mice are predominantly located in alveolar compartments, driving alveolar differentiation of epithelial progenitors via Wnt pathway activation. In contrast, in pigs and humans, these cells are situated in a unique sub-basal position adjacent to the airway epithelium. In fetal stages a pattern of LGR5 expression during lung bud tip formation is evident in humans and pigs but is lacking in mice. Species differences with respect to LGR5 expression have also been observed in the skin, intestines, and cochlea further reinforcing the need for careful selection of appropriate translational animal models. This paper discusses the potential utility of the LGR5+ pig model in exploring the role of LGR5+ cells in tissue development and regeneration with the goal of translating these findings into human and animal clinical applications.

Keywords: LGR5, Gene edited pigs, Organ stem cells, Regenerative Medicine, Animal Models

Received: 14 Mar 2024; Accepted: 15 May 2024.

Copyright: © 2024 Hill, Murphy, Polkoff, Edwards, Walker, Moatti, Greenbaum and Piedrahita. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Mx. Jorge A. Piedrahita, Comparative Medicine Institute, North Carolina State University, Raleigh, 27695, North Carolina, United States